<prompt> Chimeric human murine monoclonal antibodyare -AdalimumabRituximabMuromonabTrastuzumab  <response>: Monoclonal mouse IgG1 antibody against human CD20 Rituximab has been approved by the FDA for the treatment of various lymphoid malignancies, including B-cell non-Hodgkins lymphoma and B-cell chronic lymphocytic leukaemia also used in treatment of ebola . Ref Harrison20th edition pg 1078 